Cardisure 3.5 mg/ml oral solution for dogs
Cardisure 3.5 mg/ml oral solution for dogs
Authorised
- Pimobendan
Product identification
Medicine name:
Cardisure 3.5 mg/ml oral solution for dogs
Active substance:
- Pimobendan
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pimobendan3.50/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC01CE90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Brown high-density polyethylene bottles fitted with white polypropylene child resistant caps, and low-density polyethylenesyringe adaptors.A low-density polyethylene oral dosing syringe with graduations is supplied with the product.Pack size:Carton box containing 1 bottle of 42 ml and a 1.5 ml dosing syringe
- Brown high-density polyethylene bottles fitted with white polypropylene child resistant caps, and low-density polyethylenesyringe adaptors.A low-density polyethylene oral dosing syringe with graduations is supplied with the product.Pack size:Carton box containing 1 bottle of 168 ml and a 3 ml dosing syringe
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Genera d.d.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V546017
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0421/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Sweden
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 6/09/2026